|
CA1339210C
(en)
|
1988-05-31 |
1997-08-05 |
John Lewicki |
Recombinant techniques for production of novel natriuretic and vasodilator peptides
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US6406697B1
(en)
|
1989-02-23 |
2002-06-18 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US6541610B1
(en)
|
1989-09-05 |
2003-04-01 |
Immunex Corporation |
Fusion proteins comprising tumor necrosis factor receptor
|
|
ES2073751T3
(es)
|
1990-04-20 |
1995-08-16 |
Hisayuki Matsuo |
Nuevo peptido con actividad fisiologica de origen porcino.
|
|
JP2930380B2
(ja)
|
1990-07-13 |
1999-08-03 |
壽之 松尾 |
ブタ由来新規生理活性ペプチド（ｃｎｐ―５３）
|
|
JP3026351B2
(ja)
|
1990-07-13 |
2000-03-27 |
壽之 松尾 |
ブタｃｎｐ遺伝子及び前駆体蛋白
|
|
JP2977159B2
(ja)
|
1990-09-07 |
1999-11-10 |
壽之 松尾 |
カエル由来新規生理活性ペプチド（カエルｃｎｐ）
|
|
JP2977158B2
(ja)
|
1990-09-07 |
1999-11-10 |
壽之 松尾 |
トリ由来新規生理活性ペプチド（ニワトリｃｎｐ）
|
|
JP3026352B2
(ja)
|
1990-09-11 |
2000-03-27 |
壽之 松尾 |
ラットＣＮＰｃＤＮＡ及び前駆体蛋白
|
|
JP3026354B2
(ja)
|
1990-09-27 |
2000-03-27 |
壽之 松尾 |
ヒトｃｎｐ遺伝子及び前駆体蛋白
|
|
JP2809533B2
(ja)
|
1991-01-31 |
1998-10-08 |
壽之 松尾 |
Ｃｎｐ類似体ペプチド
|
|
WO1992020371A1
(en)
|
1991-05-10 |
1992-11-26 |
Celtrix Pharmaceuticals, Inc. |
Targeted delivery of bone growth factors
|
|
WO1994020534A1
(en)
|
1993-03-03 |
1994-09-15 |
Mayo Foundation For Medical Education And Research |
Vasonatrin peptide and analogs thereof
|
|
WO1995005455A1
(en)
|
1993-08-13 |
1995-02-23 |
Rijksuniversiteit Te Groningen |
Pharmaceutical composition comprising phosphatase or a derivative thereof
|
|
US5665704A
(en)
|
1993-11-12 |
1997-09-09 |
Genentech, Inc. |
Receptor specific atrial natriuretic peptides
|
|
US5846932A
(en)
|
1993-11-12 |
1998-12-08 |
Genentech, Inc. |
Receptor specific atrial natriuretic peptides
|
|
DE69432123T2
(de)
|
1993-11-12 |
2004-01-08 |
Genentech, Inc., South San Francisco |
Rezeptor spezifische atrio-natriuretische peptide
|
|
US6525022B1
(en)
|
1993-11-12 |
2003-02-25 |
Genentech, Inc. |
Receptor specific atrial natriuretic peptides
|
|
AU2671795A
(en)
|
1994-06-02 |
1996-01-04 |
Boehringer Mannheim Gmbh |
Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
|
|
JPH0870875A
(ja)
|
1994-09-05 |
1996-03-19 |
Tosoh Corp |
組換えアルカリフォスファタ−ゼ融合タンパク質
|
|
US5863782A
(en)
|
1995-04-19 |
1999-01-26 |
Women's And Children's Hospital |
Synthetic mammalian sulphamidase and genetic sequences encoding same
|
|
CA2269656A1
(en)
|
1996-10-22 |
1998-04-30 |
Genentech, Inc. |
Receptor specific brain natriuretic peptide (bnp)
|
|
US6028055A
(en)
|
1996-10-22 |
2000-02-22 |
Genetech, Inc. |
Receptor selective BNP
|
|
WO2000053755A2
(en)
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor
|
|
US6455495B1
(en)
|
1997-02-14 |
2002-09-24 |
The Salk Institute For Biological Studies |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
NZ506839A
(en)
|
1998-03-09 |
2003-05-30 |
Zealand Pharma As |
Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
|
CA2245903A1
(en)
|
1998-09-28 |
2000-03-28 |
Mcgill University |
Use of pex in the treatment of metabolic bone diseases
|
|
CA2260376A1
(en)
|
1999-02-11 |
2000-08-11 |
Universite De Montreal |
New metalloproteases of the neprilysin family
|
|
CA2262056A1
(en)
|
1999-02-24 |
2000-08-24 |
Guy Boileau |
Composition, methods and reagents for the synthesis of a soluble form of human pex
|
|
EP1176985A2
(en)
|
1999-04-28 |
2002-02-06 |
Vectramed, Inc. |
Enzymatically activated polymeric drug conjugates
|
|
US20040266673A1
(en)
|
2002-07-31 |
2004-12-30 |
Peter Bakis |
Long lasting natriuretic peptide derivatives
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
CA2373680C
(en)
|
1999-05-17 |
2008-07-29 |
Conjuchem Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
US6849714B1
(en)
|
1999-05-17 |
2005-02-01 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
JP2000327583A
(ja)
|
1999-05-17 |
2000-11-28 |
Medei Sci Puraningu:Kk |
骨指向性ホルモン誘導体
|
|
DE19942230C2
(de)
|
1999-09-03 |
2003-09-25 |
Wolf-Georg Forssmann |
Verwendung natriuretischer Peptide als antibiotisch wirksame Subsanzen zur Behandlung von bakteriellen Infektionen
|
|
ES2284545T3
(es)
|
1999-11-16 |
2007-11-16 |
Genzyme Corporation |
Vectores y transgenes con elementos reguladores para la administracion de genes del higado.
|
|
US6407211B1
(en)
|
1999-12-17 |
2002-06-18 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic peptides
|
|
AU2583901A
(en)
|
1999-12-17 |
2001-06-25 |
Ariad Pharmaceuticals, Inc. |
Proton pump inhibitors
|
|
JP4237375B2
(ja)
|
2000-03-31 |
2009-03-11 |
アスビオファーマ株式会社 |
虚血性疾患の処置又は予防に用いる医薬組成物
|
|
ES2232613T3
(es)
|
2000-04-26 |
2005-06-01 |
Cellegy Pharmaceuticals, Inc |
Formulaciones y metodos de utilizacion de agentes mimeticos del oxido nitrico contra un fenotipo celular maligno.
|
|
US20050142217A1
(en)
|
2000-04-26 |
2005-06-30 |
Adams Michael A. |
Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
|
|
EP1502604A1
(en)
|
2000-04-26 |
2005-02-02 |
Cellegy Pharmaceuticals, Inc |
Use of nitric oxide mimetics in cancer treatment
|
|
US7678391B2
(en)
|
2000-04-26 |
2010-03-16 |
Queen's University At Kingston |
Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
|
|
US6830885B1
(en)
|
2000-08-18 |
2004-12-14 |
Phenogene Therapeutiques Inc. |
Nucleic acid molecule, method and kit for selecting a nucleic acid having a desired feature
|
|
AU2001287429B2
(en)
|
2000-08-23 |
2005-08-18 |
Alexion Pharmaceuticals, Inc. |
Method and compositions for promoting osteogenesis
|
|
US6436386B1
(en)
|
2000-11-14 |
2002-08-20 |
Shearwater Corporation |
Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
|
|
IL155812A0
(en)
|
2000-12-07 |
2003-12-23 |
Lilly Co Eli |
Glp-1 fusion proteins
|
|
JP2002178279A
(ja)
|
2000-12-12 |
2002-06-25 |
Ulvac Japan Ltd |
基板搬送方法
|
|
AU2002255478A1
(en)
|
2001-01-10 |
2002-09-12 |
Pe Corporation (Ny) |
Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
|
|
JP2002246704A
(ja)
|
2001-02-16 |
2002-08-30 |
Philips Japan Ltd |
電子装置及び回路装置
|
|
IL142118A0
(en)
|
2001-03-20 |
2002-03-10 |
Prochon Biotech Ltd |
Method and composition for treatment of skeletal dysplasias
|
|
US20020183276A1
(en)
|
2001-03-23 |
2002-12-05 |
Burnham Institute |
Compositions and methods for modulating bone mineral deposition
|
|
US7888372B2
(en)
|
2001-03-23 |
2011-02-15 |
National Institutes Of Health (Nih) |
Compositions and methods for modulating bone mineral deposition
|
|
ATE437221T1
(de)
|
2001-05-14 |
2009-08-15 |
Gbp Ip Llc |
Lentivirale vektoren kodierend für gerinnungsfaktoren für die gentherapie
|
|
WO2003092581A2
(en)
|
2001-07-16 |
2003-11-13 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
|
BRPI0203172B8
(pt)
|
2001-09-28 |
2021-05-25 |
Nakao Kazuwa |
composição farmacêutica para acondroplasia
|
|
US20050202442A1
(en)
|
2003-12-15 |
2005-09-15 |
Morris David W. |
Novel therapeutic targets in cancer
|
|
ATE505480T1
(de)
|
2001-12-20 |
2011-04-15 |
Enobia Pharma Inc |
Knochenpolypeptid-1
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
US20080194481A1
(en)
|
2001-12-21 |
2008-08-14 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
|
US20030158132A1
(en)
|
2002-01-22 |
2003-08-21 |
Genvec, Inc. |
Method for enhancing bone density or formation
|
|
JP2005527510A
(ja)
|
2002-03-06 |
2005-09-15 |
セレジー ファーマシューティカルズ インコーポレーティッド |
癌の治療において一酸化窒素模倣体を使用するための製剤および方法
|
|
US20040077537A1
(en)
|
2002-03-18 |
2004-04-22 |
Schreiner George F. |
Method for treating congestive heart failure
|
|
US20050113286A1
(en)
|
2002-03-18 |
2005-05-26 |
Schreiner George F. |
Methods for treating congestive heart failure
|
|
IL149562A0
(en)
|
2002-05-09 |
2002-11-10 |
Prochon Ltd |
Fgf variants and methods for use thereof
|
|
CA2433479A1
(en)
|
2002-07-22 |
2004-01-22 |
F. Hoffmann-La Roche Ag |
Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof
|
|
JP2006514607A
(ja)
|
2002-07-31 |
2006-05-11 |
コンジュケム，インコーポレーテッド |
長時間持続性ナトリウム排泄増加性ペプチド誘導体
|
|
US20060110359A1
(en)
|
2002-09-06 |
2006-05-25 |
Juan Sanchez-Ramos |
Cellular delivery of natriuretic peptides
|
|
EP1562990B1
(en)
|
2002-11-18 |
2010-07-21 |
Syn X Pharma, Inc. |
Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
|
|
WO2004047871A2
(en)
|
2002-11-26 |
2004-06-10 |
Nobex Corporation |
Modified naturetic compounds, conjugates, and uses thereof
|
|
US7648962B2
(en)
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
|
AU2003291867A1
(en)
|
2002-12-03 |
2004-06-23 |
Biomep Inc. |
Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
|
|
WO2004062555A2
(en)
|
2003-01-13 |
2004-07-29 |
Gudrun Rappold-Hoerbrand |
Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
|
|
AU2004213432A1
(en)
|
2003-02-14 |
2004-09-02 |
Sagres Discovery, Inc. |
Novel therapeutic targets in cancer
|
|
US7488713B2
(en)
|
2004-03-18 |
2009-02-10 |
University Of South Florida |
Cancer treatment using C-type natriuretic peptides
|
|
US7341838B2
(en)
|
2003-04-17 |
2008-03-11 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
|
JP2007501021A
(ja)
|
2003-05-30 |
2007-01-25 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
遺伝子操作された定常領域を含む、抗体および融合タンパク質
|
|
DE602004030342D1
(de)
|
2003-06-17 |
2011-01-13 |
Otago Innovation Ltd |
Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
|
|
WO2005000095A2
(en)
|
2003-06-20 |
2005-01-06 |
Mayo Foundation For Medical Education And Research |
Isoforms of brain natriuretic peptide
|
|
WO2005052593A1
(en)
|
2003-10-29 |
2005-06-09 |
The University Of Leicester |
Detection
|
|
US7431915B2
(en)
|
2003-10-31 |
2008-10-07 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
|
ES2383300T3
(es)
|
2003-11-13 |
2012-06-20 |
Hanmi Holdings Co., Ltd |
Fragmento Fc de IgG para un vehículo de fármacos y procedimiento para su preparación
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
EP1720562A4
(en)
|
2004-01-15 |
2009-10-28 |
Scios Inc |
METHOD FOR TREATING CARDIAL REMODELING AFTER MYOCARDIAL DAMAGE
|
|
CA2554599A1
(en)
|
2004-01-27 |
2005-08-11 |
Compugen Usa, Inc. |
Novel brain natriuretic peptide variants and methods of use thereof
|
|
US20080182299A1
(en)
|
2004-01-27 |
2008-07-31 |
Compugent Ltd. |
Novel brain natriuretic peptide variants and methods of use thereof
|
|
WO2005094890A1
(ja)
|
2004-03-31 |
2005-10-13 |
Kazuwa Nakao |
身長増加用組成物
|
|
ES2465141T3
(es)
|
2004-03-31 |
2014-06-05 |
Kazuwa Nakao |
Remedio o medicamento preventivo para la artritis
|
|
JP2005292718A
(ja)
|
2004-04-05 |
2005-10-20 |
Furukawa Electric Co Ltd:The |
光導波路、光導波路モジュールおよび光導波路の作成方法
|
|
CA2559228C
(en)
|
2004-04-21 |
2016-06-21 |
Enobia Pharma Inc. |
Bone delivery conjugates and method of using same to target proteins to bone
|
|
JP2007537263A
(ja)
|
2004-05-10 |
2007-12-20 |
ノバセア インコーポレイティッド |
活性ビタミンｄ化合物による動脈再狭窄の予防法
|
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
|
US7972593B2
(en)
|
2004-06-10 |
2011-07-05 |
Saint Louis University |
Delivery of therapeutic agents to the bone
|
|
US7863238B2
(en)
|
2004-06-10 |
2011-01-04 |
Saint Louis University |
Proteins with an attached short peptide of acidic amino acids
|
|
US20070081986A1
(en)
|
2005-10-07 |
2007-04-12 |
Shunji Tomatsu |
Beta-glucuronidase with an attached short peptide of acidic amino acids
|
|
WO2006005140A2
(en)
|
2004-07-15 |
2006-01-19 |
The University Of Queensland |
Proteinaceous compounds and uses therefor
|
|
US20090142347A1
(en)
|
2004-09-29 |
2009-06-04 |
The Burnham Institute For Medical Research |
Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification
|
|
JP2008521575A
(ja)
|
2004-12-01 |
2008-06-26 |
ジェンザイム・コーポレイション |
肝臓を標的とした遺伝物質の送達方法
|
|
PL1865976T3
(pl)
|
2005-04-07 |
2012-11-30 |
Cardiorentis Ag |
Zastosowanie peptydu natriuretycznego do leczenia niewydolności serca
|
|
US8008443B2
(en)
|
2005-04-26 |
2011-08-30 |
Medimmune, Llc |
Modulation of antibody effector function by hinge domain engineering
|
|
US20070042957A1
(en)
|
2005-08-19 |
2007-02-22 |
Mayo Foundation For Medical Education And Research |
Type v phosphodiesterase inhibitors and natriuretic polypeptides
|
|
US7470668B2
(en)
|
2005-08-24 |
2008-12-30 |
Enobia Pharma Inc. |
Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof
|
|
AU2006343306A1
(en)
|
2005-09-06 |
2007-11-15 |
Zelos Therapeutics, Inc. |
Parathyroid hormone analogues and methods of use
|
|
US7803901B2
(en)
|
2005-09-16 |
2010-09-28 |
Mayo Foundation For Medical Education And Research |
Polypeptides with natriuresis activity
|
|
US20080227713A1
(en)
|
2005-10-03 |
2008-09-18 |
Protter Andrew A |
Oxidized Human Bnp
|
|
RU2316334C2
(ru)
|
2005-12-19 |
2008-02-10 |
Медитек Индастриз ЛЛС |
Способ активации утраченных двигательных функций, а также определения эффективности их восстановления при повреждении центральной нервной системы
|
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
|
US8575070B2
(en)
|
2006-02-20 |
2013-11-05 |
Phylogica Limited |
Methods of constructing and screening libraries of peptide structures
|
|
US8784833B2
(en)
|
2006-06-27 |
2014-07-22 |
Saint Louis University |
Prenatal enzyme replacement therapy for hypophosphatasia
|
|
WO2008053362A2
(en)
|
2006-06-30 |
2008-05-08 |
Interface Biologics, Inc. |
Bioresponsive polymers
|
|
CN101501067B
(zh)
|
2006-08-08 |
2013-01-16 |
梅约医学教育与研究基金会 |
利尿和利尿钠的多肽
|
|
US7825092B2
(en)
|
2006-08-08 |
2010-11-02 |
University Of South Florida |
Dendroaspis natriuretic peptide for treatment of cancer
|
|
CN106008699A
(zh)
|
2006-09-08 |
2016-10-12 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
|
US8283318B2
(en)
|
2006-09-08 |
2012-10-09 |
Mayo Foundation For Medical Education And Research |
Aquaretic and natriuretic polypeptides lacking vasodilatory activity
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
US20100168443A1
(en)
|
2006-11-02 |
2010-07-01 |
University Of Virginia Patent Foundation |
Ethoid-Containing Compounds, Methods for Preparing Ethoid-Containing Compounds, and Methods of Use
|
|
JP5645408B2
(ja)
|
2006-11-16 |
2014-12-24 |
カイ ファーマシューティカルズ インコーポレーティッド |
副甲状腺機能亢進症および高カルシウム血症性障害の治療のためのポリカチオン性カルシウムモジュレーターペプチド
|
|
US20080181903A1
(en)
|
2006-12-21 |
2008-07-31 |
Pdl Biopharma, Inc. |
Conjugate of natriuretic peptide and antibody constant region
|
|
ATE554395T1
(de)
|
2007-03-12 |
2012-05-15 |
Biomedica Medizinprodukte Gmbh & Co Kg |
Diagnose septischer komplikationen
|
|
EP1985697A1
(en)
|
2007-04-27 |
2008-10-29 |
AM-Pharma B.V. |
Modified phosphatases
|
|
KR20080098216A
(ko)
|
2007-05-04 |
2008-11-07 |
한미약품 주식회사 |
캐리어 물질을 이용한 나트륨 배설 펩타이드 약물 결합체
|
|
HUE031655T2
(hu)
|
2007-05-11 |
2017-07-28 |
Alexion Pharma Inc |
Csontot targetáló alkálikus foszfatáz, készletek és eljárások alkalmazásukra
|
|
EP2158318A2
(en)
|
2007-05-14 |
2010-03-03 |
Biogen Idec MA, Inc. |
Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
|
|
US20100310561A1
(en)
|
2007-06-06 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Natriuretic fusion proteins
|
|
WO2008154543A2
(en)
|
2007-06-11 |
2008-12-18 |
Abbott Biotechnology Ltd. |
Methods for treating juvenile idiopathic arthritis
|
|
US20110077383A1
(en)
|
2007-07-03 |
2011-03-31 |
Medimmune, Llc |
Hinge domain engineering
|
|
AP2009005091A0
(en)
|
2007-07-06 |
2009-12-31 |
Theratechnologies Inc |
Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (ALPHA-MSH) and atrial natriuretic protein (ANP) and uses in hypertension andacute kidney injury
|
|
CN101541957B
(zh)
|
2007-07-20 |
2013-08-14 |
梅约医学教育与研究基金会 |
利尿钠多肽
|
|
WO2009042294A2
(en)
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
JP2010536341A
(ja)
|
2007-08-15 |
2010-12-02 |
アムニクス， インコーポレイテッド |
生物学的に活性なポリペプチドの特性を改変するための組成物および方法
|
|
EP2185183B1
(en)
|
2007-09-11 |
2016-03-16 |
Cardiopep Pharma GmbH |
Use of natriuretic peptides for treating angioedema syndromes
|
|
JP2010539002A
(ja)
|
2007-09-11 |
2010-12-16 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
ウロジラチンの治療剤としての使用
|
|
WO2009033690A1
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Bfgf (119-126) for therapeutic applications
|
|
KR20100056508A
(ko)
|
2007-09-11 |
2010-05-27 |
몬도바이오테크 래보래토리즈 아게 |
폐렴 연쇄상 구균 감염의 치료를 위한 ｂｆｇｆ １－２４ 및 임의의 （ａｒｇ ８）바소프레신의 용도
|
|
WO2009039982A2
(en)
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
US20100204145A1
(en)
|
2007-09-11 |
2010-08-12 |
Dorian Bevec |
Use of a peptide as a therapeutic agent
|
|
WO2009036448A2
(en)
|
2007-09-15 |
2009-03-19 |
Mayo Foundation For Medical Education And Research |
Natriuretic peptide receptor-c agonists
|
|
EP2217620A2
(en)
|
2007-11-21 |
2010-08-18 |
BioMarin Pharmaceutical Inc. |
Variants of c-type natriuretic peptide
|
|
WO2009086126A2
(en)
|
2007-12-21 |
2009-07-09 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides
|
|
EP2080812A1
(en)
|
2008-01-18 |
2009-07-22 |
Transmedi SA |
Compositions and methods of detecting post-stop peptides
|
|
KR101350251B1
(ko)
|
2008-05-23 |
2014-01-14 |
다이이찌 산쿄 가부시키가이샤 |
목적 펩타이드의 혈장내 반감기 연장 작용을 가진 펩타이드
|
|
WO2009149161A2
(en)
|
2008-06-06 |
2009-12-10 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling
|
|
WO2009156481A1
(en)
|
2008-06-25 |
2009-12-30 |
Ascendis Pharma As |
Pegylated bnp
|
|
CN102131822A
(zh)
|
2008-06-26 |
2011-07-20 |
阿塞勒隆制药公司 |
进行激活素-ActRIIa拮抗剂给药和监测受治疗患者的方法
|
|
US8741842B2
(en)
|
2008-07-02 |
2014-06-03 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic polypeptides with unique pharmacologic profiles
|
|
MX2011000861A
(es)
|
2008-07-23 |
2011-06-21 |
Hanmi Holdings Co Ltd |
Un complejo polipeptidico que consiste en un polimero no-peptidil que posee tres terminaciones funcionales.
|
|
US20100093678A1
(en)
|
2008-10-10 |
2010-04-15 |
The University Of Georgia Research Foundation, Inc |
Compositions and methods of the treatment of obesity and osteoporosis
|
|
US8642550B2
(en)
|
2008-10-24 |
2014-02-04 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic peptides without hypotensive inducing capability
|
|
US8455438B2
(en)
|
2008-12-29 |
2013-06-04 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides for reducing or preventing restenosis
|
|
WO2010082804A2
(en)
|
2009-01-19 |
2010-07-22 |
Hanmi Pharm. Co., Ltd. |
Method for producing physiologically active protein or peptide using immunoglobulin fragment
|
|
CA2754408A1
(en)
|
2009-03-30 |
2010-10-14 |
Boehringer Ingelheim International Gmbh |
Fusion proteins comprising canine fc portions
|
|
WO2010129655A2
(en)
|
2009-05-05 |
2010-11-11 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides having mutations within their disulfide rings
|
|
PT2432489T
(pt)
|
2009-05-20 |
2016-12-07 |
Biomarin Pharm Inc |
Variantes do péptido natriurético de tipo c
|
|
BR112012027765A2
(pt)
|
2010-04-30 |
2019-09-24 |
Enobia Pharma Inc. |
métodos, composições e kits para tratamento de distúrbios de mineralização da matriz.
|
|
WO2012088608A1
(en)
|
2010-12-27 |
2012-07-05 |
Enobia Canada Limited Partnership |
Compositions comprising natriuretic peptides and methods of use thereof
|
|
KR20140084201A
(ko)
*
|
2011-10-19 |
2014-07-04 |
알렉시온 파마 홀딩 |
알칼리성 포스파타제 및/또는 나트륨이뇨 펩티드를 포함하는 조성물 및 그의 사용 방법
|
|
CN109985228A
(zh)
|
2011-11-10 |
2019-07-09 |
凯伊药品公司 |
拟钙剂及其使用方法
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
EP2877247A1
(en)
|
2012-07-25 |
2015-06-03 |
Psioxus Therapeutics Limited |
Use of s-pindolol for treating cachexia and sarcopenia
|
|
ES2810813T3
(es)
|
2014-01-24 |
2021-03-09 |
Am Pharma Bv |
Procesamiento para recuperación y purificación de una fosfatasa alcalina
|
|
MX381052B
(es)
|
2014-06-09 |
2025-03-12 |
Ultragenyx Pharmaceutical Inc |
El control efectivo y eficaz del fosfato serico para una osificacion optima.
|
|
WO2016007873A1
(en)
*
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
|
MX389350B
(es)
|
2014-12-05 |
2025-03-19 |
Alexion Pharma Inc |
Fosfatasas alcalinas recombinantes y usos de las mismas para el tratamiento de convulsiones.
|
|
JP6868561B2
(ja)
|
2015-01-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼ欠損を有する被験者を治療する方法
|
|
CN108350440A
(zh)
|
2015-08-17 |
2018-07-31 |
阿雷克森制药公司 |
碱性磷酸酯的制造
|
|
JP6868617B2
(ja)
|
2015-09-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
|
|
JP2018533571A
(ja)
|
2015-10-30 |
2018-11-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
患者の頭蓋縫合早期癒合症を治療するための方法
|
|
WO2017155569A1
(en)
|
2016-03-08 |
2017-09-14 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
|
WO2017171871A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
JP7613826B2
(ja)
|
2016-04-01 |
2025-01-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼによって筋力低下を治療すること
|
|
US10898549B2
(en)
|
2016-04-01 |
2021-01-26 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
|
ES2887573T3
(es)
|
2016-06-27 |
2021-12-23 |
Alexion Pharma Inc |
Métodos para el tratamiento de la hipofosfatasia en niños y adolescentes
|
|
EP3500289B1
(en)
|
2016-08-18 |
2024-10-09 |
Alexion Pharmaceuticals, Inc. |
Asfotase alfa for use in treating tracheobronchomalacia
|